Table 2.
Examples of commercial products for cartilage repair
| Product | Company | Biomaterial + Cells | References |
|---|---|---|---|
| Bioseed-C | BioTissue Technologies (Freiburg, Germany) | Polylactin/polydiaxanon/fibrin + autologous chondrocytes | (Zeifang et al. 2010; Ossendorf et al. 2007; Kreuz et al. 2011) |
| Chondrosphere (ACT3D-CS/ARTHROCELL 3D) | Co.don (Teltow, Germany) | No scaffold + Autologous chondrocytes | (Becher et al. 2017; Fickert et al. 2012; Siebold et al. 2018) |
| CaReS-1S | Arthro Kinetics Biotechnology (Krems, Austria) | Murine (rat tail) type-I collagen hydrogel + autologous chondrocytes | (Petri et al. 2013; Schneider et al. 2011) |
| Biocart II | Histohenics (Waltham, Massachusetts) | Fibrin/hyaluronic acid + autologous chondrocytes | (Eshed et al. 2012; Nehrer et al. 2008) |
| Cartipatch | Tissue Bank of France (Lyon, France) | Agarose/alginate hydrogel + autologous chondrocytes | (Selmi et al. 2008) |
| NeoCart | Histogenics (Waltham, Massachusetts) | Bovine type-I collagen + autologous chondrocytes | (Anderson et al. 2017; Crawford et al. 2012; Crawford et al. 2009) |
| RevaFlex (DeNovo ET) | Isto Technologies (St. Louis, Missouri) | No scaffold + allogeneic juvenile chondrocytes | (McCormick et al. 2013) |
| Novocart 3D | TETEC Tissue Engineering Technologies (Reutlingen, Germany) | Bovine type-I collagen/chondroitin sulphate + autologous chondrocytes | (Niethammer et al. 2014; Zak et al. 2014; Niethammer et al. 2017) |